← Company intelligence

Robot maker · early

Robeauté

Corporate marketmedicalCurated record

Developing self-propelled neurosurgical microrobots ~1.8 mm long (grain-of-rice scale) that navigate through brain tissue along curved trajectories to take biopsies, deliver drugs and place sensors, aiming to reach targets conventional straight-line neurosurgery cannot. Moving from animal studies toward first human clinical trials expected in 2026, with strategic input from Brainlab.

HeadquartersParis, FR
Founded2017
Corporate funding$28M
Team11-50
Deployments0
Open roles8
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageVenture ($28M round Jan 2025 led by Plural, Cherry Ventures, Kindred Ventures)
FoundersBertrand Duplat (Co-founder & CEO), Joana Cartocci (Co-founder)
Regions servedEurope
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Robeauté neurosurgical microrobot

  • Self-propelled 1.8 mm microrobot that navigates the brain's complex structures along curved paths for targeted treatment delivery; human trials expected 2026

    vendor-stated pre-clinical microrobot capability

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordPluralCherry VenturesKindred VenturesLocalGlobeThink.HealthAPEX Ventures
HR

Hiring signal

Public job board · 2026-07-13

Open roles8

Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.

TL

Company timeline

Milestones and announcements

2025-01-13Raised $28M (EUR 27.2M) led by Plural, Cherry Ventures and Kindred Ventures to move microrobots from animal studies toward human trialsFortune
SC

Source ledger

1 unique public sources